Semisynthetic triterpenes led to the generation of selective antitrypanosomal lead compounds. (31st March 2022)
- Record Type:
- Journal Article
- Title:
- Semisynthetic triterpenes led to the generation of selective antitrypanosomal lead compounds. (31st March 2022)
- Main Title:
- Semisynthetic triterpenes led to the generation of selective antitrypanosomal lead compounds
- Authors:
- Guilhon‐Simplicio, Fernanda
Serrão, Carlos Klinger Rodrigues
Pinto, Ana Cristina da Silva
Pacheco, Paulo Anastácio Furtado
Faria, Robson Xavier
da Rocha, David Rodrigues
Ferreira, Vitor Francisco
Pereira‐Junior, Raimundo Carlos
Matheeussen, An
Baán, Adrienn
Kiekens, Filip
de Meneses Pereira, Maria
Lima, Emerson Silva
Winter, Hans De
Cos, Paul - Abstract:
- Abstract: Triterpenes α, β‐amyrin are naturally occurring molecules that can serve as building blocks for synthesizing new chemical entities. This study synthesized acyl, carboxyesther, NSAID, and nitrogenous derivatives and evaluated their antimicrobial activity. A cyclodextrin complexation method was developed to improve the solubility of the derivatives. Of the 17 derivatives tested, five exhibited activity against Trypanosoma cruzi, T . brucei, Leishmania infantum, Candida albicans, Staphylococcus aureus, and Escherichia coli . The 9a/9b mixture showed weak activity against the parasites (IC50 24.45–40.32 μM). However, it showed no activity for the other microorganisms. Derivatives 14a/14b exhibited potent activity against T . cruzi (IC50 2.0 nM) in this tested concentration did not show activity to the other microorganisms and were not cytotoxic. Derivatives 15a/15b and 16a/16b demonstrated relevant activity against the parasites (IC50 2.24–5.44 μM), but were also cytotoxic. Derivatives 17a/17b showed low activity against the tested parasites (IC50 21.70–22.79 μM), but they were selective since they did not show activity against other microorganisms. In docking studies, in general, all derivatives showed complementarity with the CYP51 binding site of the trypanosomatid mainly by hydrophobic interactions; thus, it is not conclusive that the molecules act by inhibiting this enzyme. Our results showed that triterpenes derivatives with antitrypanosomal activity could beAbstract: Triterpenes α, β‐amyrin are naturally occurring molecules that can serve as building blocks for synthesizing new chemical entities. This study synthesized acyl, carboxyesther, NSAID, and nitrogenous derivatives and evaluated their antimicrobial activity. A cyclodextrin complexation method was developed to improve the solubility of the derivatives. Of the 17 derivatives tested, five exhibited activity against Trypanosoma cruzi, T . brucei, Leishmania infantum, Candida albicans, Staphylococcus aureus, and Escherichia coli . The 9a/9b mixture showed weak activity against the parasites (IC50 24.45–40.32 μM). However, it showed no activity for the other microorganisms. Derivatives 14a/14b exhibited potent activity against T . cruzi (IC50 2.0 nM) in this tested concentration did not show activity to the other microorganisms and were not cytotoxic. Derivatives 15a/15b and 16a/16b demonstrated relevant activity against the parasites (IC50 2.24–5.44 μM), but were also cytotoxic. Derivatives 17a/17b showed low activity against the tested parasites (IC50 21.70–22.79 μM), but they were selective since they did not show activity against other microorganisms. In docking studies, in general, all derivatives showed complementarity with the CYP51 binding site of the trypanosomatid mainly by hydrophobic interactions; thus, it is not conclusive that the molecules act by inhibiting this enzyme. Our results showed that triterpenes derivatives with antitrypanosomal activity could be synthesized by an inexpensive and rapid method. Abstract : Derivatives of α, β‐amyrins showed potent activity against trypanosomatids. Complexation with sulfobutylether‐β‐cyclodextrin increasing their solubility. α, β‐amyrins may be a promising and inexpensive source of anti‐trypanosomatid. … (more)
- Is Part Of:
- Chemical biology & drug design. Volume 99:Number 6(2022)
- Journal:
- Chemical biology & drug design
- Issue:
- Volume 99:Number 6(2022)
- Issue Display:
- Volume 99, Issue 6 (2022)
- Year:
- 2022
- Volume:
- 99
- Issue:
- 6
- Issue Sort Value:
- 2022-0099-0006-0000
- Page Start:
- 868
- Page End:
- 883
- Publication Date:
- 2022-03-31
- Subjects:
- amyrins -- antitrypanosomatids -- molecular docking -- semisynthesis -- triterpenes
Drugs -- Design -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
615.19005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01253034-000000000-00000 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 ↗
http://www.blackwell-synergy.com/loi/jpp ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cbdd.14040 ↗
- Languages:
- English
- ISSNs:
- 1747-0277
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3139.120000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21492.xml